Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 21, Art. 83 (pp. 1064-1073)    |    2020       

»

About the prevention of thromboembolic complications in neurosurgical patients

Almazov National Medical Research Centre

Brief summary

Neurosurgical patients are a separate specific group of patients to whom general recommendations for the prevention of thromboembolic complications cannot be applied. On the one hand, they have an increased risk of thrombus formation, on the other hand, a high risk of bleeding in the postoperative period. We divided all neurosurgical patients into two groups: the average risk of hemorrhagic complications - if necessary, and if hemostasis has taken place, it is possible to prescribe LMWH after 48-72 hours and a high-risk group, where the decision to carry out medical prophylaxis of venous thromboembolism has a personalized approach.


Key words

pulmonary embolism, brain tumors, neurosurgical patients.

Reference list

1) Christopher M. Loftus. Anticoagulation and Hemostasis in Neurosurgery. USA: Medicine Loyola University Maywood , IL; 2016.


2) Ulfsdotter Nilsson, Karin Strandberg, Martin Engström, Peter Reinstrup. Coagulation during elective neurosurgery with hydroxyethyl starch fluid therapy: an observational study with thromboelastometry, fibrinogen and factor XIII. Perioper Med (Lond) 2016


3) A. Kotaska. Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines Thrombosis Journal, 2018


4) Rossiiskie klinicheskie rekomendacii po diagnostike, lecheniu i profilaktike venoznih tromboembolicheskih oslojnenii. Moskva; 2015.


5) Profilaktika venoznih tromboembolicheskih oslojnenii v travmatologii i ortopedii. Rossiiskie klinicheskie rekomendacii. Travmatologiya i ortopediya Rossii; 2012.


6) OST R 56377-2015 Gryppa R24 NACIONALNII STANDART ROSSIISKOI FEDERACII KLINIChESKIE REKOMENDACII (PROTOKOLI LEChENIYa); Rossiya, 2015.


7) Rekomedacii Amerikanskoi Kollegii Torakalnih vrachei po antitrombaticheskoi terapii VTEO ASSR, 2016 obnovlenie


8) Shlomit Yust-Katz, Jacob J. Mandel, Jimin Wu, Ying Yuan, Courtney Webre, Tushar A. Pawar et.al.Venous thromboembolism (VTE) and glioblastoma. Neurooncol. 124:87-94; 2015.


9) Rekomendacii Evropeiskogo kardiologicheskogo obshestva po diagnostike i lecheniu TELA ESC, 2014


10) Rekomendacii Amerikanskoi Kollegii Torakalnih vrachei po antitrombaticheskoi terapii trombozov ACCP, 2012


11) Robert Loch Macdonald. Management of Intracranial Hemorrhage in the Anticoagulated Patient. Neurosurg Clin N Am. Oct;29(4):605-613; 2018.